蛋白质工程实验室自动化市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

蛋白质工程实验室自动化市场预计在预测期内（2022-2027 年）以 12.4% 的复合年增长率增长。

蛋白质工程的自动化可以帮助科学家破译和解决蛋白质错误行为的奥秘，例如错误折迭、聚集和异常运动。 结果是更有效的药物发现。 蛋白质工程行业自动化的主要驱动力之一是对蛋白质药物的需求超过非蛋白质药物的快速增长以及生活方式疾病的日益流行。

主要亮点

• 蛋白质和能量营养不良 (PEM) 在新兴国家/地区的农村地区日益严重。 指的是一组疾病，包括夸希奥科尔症、消瘦症和夸希奥科尔氏症过渡期消瘦症。 因此，kwashiorkor 的发病率因地区而异。 在美国很少见。 拉丁美洲、东南亚、刚果、牙买加、波多黎各和南非受到影响。 因此，蛋白质缺乏症的发生频率不断增加，正在推高整体市场需求。
• 医疗保健业务受到政府举措增加的影响，包括蛋白质工程的研发和宣传计划的讚助。 因此，政府抢先资助了几项研究计划。 例如，Protein Technologies Ltd (PTL) 已获得英国政府技术战略委员会（现为 Innovate UK）的资助，用于开创性的蛋白质工程研究。
• 蛋白质工程在农化业务领域也具有巨大潜力，因为它可以改善□的功能、提高作物产量并促进生物燃料的生产。 作为实现未来农业高产所需的技术，它也有望发挥重要作用。
• 自 COVID-19 爆发以来，实验室已将其场地和资源转变为 COVID-19 检测设施，并增加了自动化设备的使用。 华盛顿大学的一个实验室就是第一个例子。 在 Broad Institute 宣布将其临床处理实验室转变为大型 COVID-19 测试设施之后，他发表了上述言论。

蛋白质工程实验室自动化市场趋势

自动液体处理设备占有最大市场份额

• 液体处理器通常用于生物化学和化学实验室。 自动液体处理机器人有助于在实验室中分配样品和其他液体。 自动液体处理器可以最大限度地减少运行时间并最大限度地提高准确性。 此外，液体处理器能够处理各种纳升体积，证明了它们在分配任务中的实用性。
• 领先的公司不断投资开发优质产品，为自动液体处理器开发树立标桿，并有效提高生产力。 能够处理微量液体的液体处理器的发展促进了市场上模块化实验室自动化系统的快速发展。
• 根据机器人行业协会的数据，自动液体处理机、自动板处理机和机械臂等工业机器人是生命科学领域增长第三快的部分，满足了需求。
• Parker 表示，生命科学领域的机器人趋势之一是简化机器人分析仪中的流体学。 这种趋势源于这样一个事实，即临床实验室和医院在处理关键样本时不能停止设备。 机器人系统过去在移液装置的尖端有 50 根针头并使用许多管子，最近使用了一种特殊的阀组，无需管子并减少了故障的可能性。我来了。 该歧管基本上将洩漏的可能性降至最低。

北美市场份额最大

• 北美长期以来一直是临床研究的先驱。 该地区是辉瑞、诺华、葛兰素史克、强生和诺华等主要製药公司的所在地。 该地区还拥有最集中的合同研究组织 (CRO)。 重要的 CRO 包括 Laboratory Corp. of America Holdings、IQVIA、Syneos Health 和 Parexel International Corp。 行业巨头的存在和严格的 FDA 法规使该地区的市场竞争激烈。 为了在竞争中获得优势，该地区的基因组研究机构越来越多地在他们的实验室中采用机器人技术和自动化技术。
• 尤其是在美国，基因组学行业仍在增长，预计在未来几年内还会增长。 新基因组测序技术的可用性、完善的医疗保健基础设施和不断增长的老年人口是收入增长的主要驱动力。 在美国，由于增长和对效率的需求，血液中心引入了全自动无人值守系统来执行类型测试、筛查和传染病测试。
• 许多公司都因其广泛的研发能力而致力于创新。 例如，2021 年 8 月，礼来公司将与 Zias 合作，在圣地亚哥开设一个全自动礼来生命科学工作室实验室。 自动化的各个领域可以包括纯化、蛋白质工程、化合物合成、生物测试和分析，在这个实验室使用 MagnaMotion Track。

蛋白质工程市场实验室自动化竞争对手分析

由于大大小小的参与者将其产品出口到许多国家，蛋白质工程市场的实验室自动化具有一定的竞争力。 主要参与者采用的主要策略是开发、合作伙伴关係和併购方面的技术进步。 主要参与者包括 Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Siemens Healthineers、Danaher Corporation 和 PerkinElmer。 该市场的最新发展包括：

• 2021 年 11 月 - PKeye Workflow Monitor 是 PerkinElmer 基于云的工具，使实验室工作人员能够实时远程管理和监控 PerkinElmer 仪器和流程。 PKeye Workflow Monitor 使科学家和研究人员能够访问和了解实验室流程。
• 2021 年 3 月 - 安捷伦科技公司宣布推出 MassHunter BioConfirm、MassHunter Networked Workstation 11.0 和 MassHunter Workstation Plus 11.0。 此外，安捷伦还发布了 VWorks 14.0 Plus，为其自动化液体处理平台增加了合规性功能。

其他福利。

• Excel 格式的市场预测 (ME) 表
• 3 个月的分析师支持

内容

第一章介绍

• 研究假设和市场定义
• 调查范围

第二章研究方法论

第 3 章执行摘要

第 4 章市场洞察

• 市场概览
• 价值链/供应链分析
• 产业吸引力 - 波特五力分析
  • 新进入者的威胁
  • 买家的议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 评估 COVID-19 对行业的影响

第 5 章市场动态

• 市场驱动力
  • 通过物联网实现实验室数字化转型的趋势不断增强
  • 高效管理大量数据
• 市场製约因素
  • 昂贵的初始设置

第 6 章市场细分

• 按设备
  • 自动液体处理器
  • 自动印版机
  • 机械臂
  • 自动存储和恢復系统 (AS/RS)
  • 其他设备
• 按地区
  • 北美
  • 欧洲
  • 亚太地区
  • 世界其他地方

第七章竞争格局

• 公司简介
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation/Beckman Coulter
  • Hudson Robotics Inc.
  • Becton, Dickinson and Company
  • Synchron Lab Automation
  • Agilent Technologies Inc.
  • Siemens Healthineers AG
  • Tecan Group Ltd
  • Perkinelmer Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd

第八章投资分析

第九章市场机会与未来趋势

The lab automation in protein engineering market is expected to register a CAGR of 12.4% over the forecast period (2022-2027). Protein engineering automation can aid scientists in deciphering and solving the mysteries of protein malfunction, such as misfolding, aggregation, and unusual movement. As a result, more effective medication discovery will be possible. One of the primary drivers for automation in the protein engineering industry is the fast-expanding demand for protein medications over non-protein pharmaceuticals and the increased prevalence of lifestyle disorders.

Key Highlights

• Protein-energy malnutrition (PEM) is rising in emerging economies' rural communities. It refers to a collection of illnesses that includes kwashiorkor, marasmus, and marasmus-kwashiorkor transitional phases. As a result, the incidence of kwashiorkor varies by region. It is quite uncommon in the United States. Central America, Southeast Asia, Congo, Jamaica, Puerto Rico, and South Africa are impacted. As a result, the rising frequency of protein-deficiency illnesses boosts total market demand.
• The healthcare business has been affected by a growing number of government efforts, such as sponsoring R&D for protein engineering and awareness programs. As a result, the government is funding several research initiatives ahead of time. For example, Protein Technologies Ltd (PTL) obtained money from the UK government's Technology Strategy Board (now Innovate UK) for their ground-breaking protein engineering research.
• Protein engineering also has a lot of potential in the agrochemical business because it can lead to better-functioning enzymes, boosting crop yields, or making biofuel production easier. It is also anticipated to play a vital role as a technique for achieving the higher agricultural yields required to satisfy future needs.
• Since the outbreak of COVID-19, labs have been turning their premises and resources into COVID-19 testing facilities, increasing automation equipment use. The University of Washington's laboratories were the first to do so. The statement came after the Broad Institute announced that its clinical processing lab would be converted into a large-scale COVID-19 testing facility.

Lab Automation in Protein Engineering Market Trends

Automated Liquid Handler Equipment Accounted for the Largest Market Share

• Liquid handlers are usually employed in biochemical and chemical laboratories. Automated liquid handling robots help in dispensing samples and other liquids in laboratories. Automated liquid handlers minimize run times and maximize accuracy. Moreover, liquid handlers are capable of operating across a wide range of volumes, extending into nanolitres, thus proving their usefulness in dispensing operations.
• Leading companies have set the benchmark for the development of automated liquid handlers and are constantly investing in developing premium products to increase productivity effectively. The evolution of the liquid handlers, capable of handling minute volumes of liquids, has contributed to the rapid development of modular lab automation systems in the market.
• According to the Robotic Industries Association, the life science sector has the third-highest growth in industrial robots, in terms of automated liquid handlers, automated plate handlers, robotic arms, and others, to meet the demand.
• According to Parker, one of the trends in life science robotics is fluidics getting simpler in robotic analyzers. This trend arose because clinical laboratories and hospitals cannot afford an instrument to go down when critical samples are involved. Certain robotic systems that used to have 50 needles on the end of a dispensing unit and lots of tubing increasingly use special valve manifolds that eliminate the need for tubing and result in less chance for failure. The manifolds basically minimize the chance of leakage.

North America Occupied the Largest Market Share

• North America has been a pioneer in clinical research for years. This region is home to major pharmaceutical companies, like Pfizer, Novartis, GlaxoSmithKline, J&J, and Novartis. The part also has the highest concentration of contract research organizations (CROs). Some of the significant CROs are Laboratory Corp. of America Holdings, IQVIA, Syneos Health, and Parexel International Corp. Owing to the presence of all the major players in the industry and stringent FDA regulations, the market is very competitive in the region. To gain an advantage over competitors, the genomics research organizations in the area are increasingly adopting robotics and automation in labs.
• The genomic industry, especially in the United States, is still growing and is expected to increase over the coming years. The availability of new genome sequencing technologies, well-established healthcare infrastructure, and the increasing geriatric population are significant contributing factors to revenue growth. In the United States, the need to accommodate growth and the drive to boost efficiency are priming blood centers to acquire fully automated walkaway systems to perform types and screens or test specimens for infectious diseases.
• Many companies are involved in innovation due to their extensive R&D capabilities. For instance, in August 2021, Eli Lilly and Company, in collaboration with Ziath, will open the completely automated Lilly Life Sciences Studio lab in San Diego. Individual areas of automation can encompass purification, protein engineering, compound synthesis, biological testing, and analysis in the lab, which is equipped with a Magnamotion track.

Lab Automation in Protein Engineering Market Competitor Analysis

The lab automation in protein engineering market is moderately competitive, owing to many small and big players exporting products to many countries. The key strategies adopted by the major players are technological advancement in development, partnerships, and merger and acquisition. Some of the major players in the market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, and PerkinElmer. Some of the recent developments in the market are:

• November 2021 - PKeye Workflow Monitor, a cloud-based tool from PerkinElmer, allowed lab employees to manage and monitor PerkinElmer instruments and processes in real-time remotely. The PKeye Workflow Monitor provides access to and visibility into laboratory processes for scientists and researchers.
• March 2021 - Agilent Technologies Inc. announced the launch of MassHunter BioConfirm, MassHunter Networked Workstation 11.0 and MassHunter Workstation Plus 11.0. In addition, Agilent also introduced VWorks 14.0 Plus, which adds compliance-enabling capabilities to the company's automated liquid handling platform.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

• 4.1 Market Overview
• 4.2 Value Chain/Supply Chain Analysis
• 4.3 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.3.1 Threat of New Entrants
  • 4.3.2 Bargaining Power of Buyers
  • 4.3.3 Bargaining Power of Suppliers
  • 4.3.4 Threat of Substitute Products
  • 4.3.5 Intensity of Competitive Rivalry
• 4.4 Assessment of the COVID-19 Impact on the Industry

5 MARKET DYNAMICS

• 5.1 Market Drivers
  • 5.1.1 Growing Trend of Digital Transformation for Laboratories with IoT
  • 5.1.2 Effective Management of the Huge Amount of Data Generated
• 5.2 Market Restraints
  • 5.2.1 Expensive Initial Setup

6 MARKET SEGMENTATION

• 6.1 By Equipment
  • 6.1.1 Automated Liquid Handlers
  • 6.1.2 Automated Plate Handlers
  • 6.1.3 Robotic Arms
  • 6.1.4 Automated Storage and Retrieval Systems (AS/RS)
  • 6.1.5 Other Equipment
• 6.2 By Geography
  • 6.2.1 North America
  • 6.2.2 Europe
  • 6.2.3 Asia-Pacific
  • 6.2.4 Rest of the World

7 COMPETITIVE LANDSCAPE

• 7.1 Company Profiles
  • 7.1.1 Thermo Fisher Scientific Inc.
  • 7.1.2 Danaher Corporation/Beckman Coulter
  • 7.1.3 Hudson Robotics Inc.
  • 7.1.4 Becton, Dickinson and Company
  • 7.1.5 Synchron Lab Automation
  • 7.1.6 Agilent Technologies Inc.
  • 7.1.7 Siemens Healthineers AG
  • 7.1.8 Tecan Group Ltd
  • 7.1.9 Perkinelmer Inc.
  • 7.1.10 Eli Lilly and Company
  • 7.1.11 F. Hoffmann-La Roche Ltd

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS